Semble Secures £30 Million in Series C Funding
Semble, a London-based company specializing in healthcare management software, announced on June 4, 2026, that it has raised £30 million in a Series C funding round. The round was led by Revaia, with additional participation from Partech, Mercia Ventures, and Octopus Ventures. Semble provides an integrated platform that simplifies workflow management for private healthcare providers, aiming to enhance the efficiency and quality of care.
Leadership and Vision
Semble was co-founded by Christoph Lippuner, who serves as CEO, and Mikael Landau, the CTO. "Our goal is to revolutionize the way private healthcare operates by making it more connected and efficient," Lippuner stated.
Strategic Use of Funds
The newly acquired funds are intended to expand Semble's platform across Europe. The company plans to enhance its technology and broaden its market reach, aiming to become Europe's most connected private healthcare platform. While specific plans for the funds were not disclosed, the investment will likely focus on technological advancements and scaling operations.
Investor Confidence
The Series C round reflects significant confidence from investors. Lead investor Revaia, along with Partech, Mercia Ventures, and Octopus Ventures, have shown strong support for Semble's vision and growth potential. This backing underscores the importance of innovation in healthcare management as the industry continues to evolve.
Future Prospects
With this fresh capital injection, Semble is poised to make substantial strides in the healthcare sector. The company plans to leverage its comprehensive platform to address the complexities of private healthcare management, offering solutions that improve both provider efficiency and patient outcomes.
As Semble continues to grow, it remains focused on its mission to simplify healthcare processes and deliver better care through technology. This funding round marks a pivotal step in that journey.